IAB - Italian Angels for Biotech
Massimo Gulisano is an accomplished academic and entrepreneur currently serving as an Affiliated Scientist at the Broad Institute of MIT and Harvard and a Visiting Scholar at Harvard University, where research is focused on stem cell and regenerative biology. Gulisano co-founded DGBiotech Srl, a spin-off from the University of Catania, specializing in sustainable biotechnology solutions, and has held various significant positions at the University of Catania, including Director of the IMPRonTe Research Centre and Full Professor in Cellular and Experimental Biology. Gulisano's extensive experience includes contributions to multiple boards and partnerships, such as member roles at the Associazione di Biologia Cellulare e del Differenziamento and Italian Angels for Biotech. Gulisano holds a Ph.D. in Medical Embryology and has pursued further education, including a Mini MBA in Global BioPharma Entrepreneurship.
This person is not in any teams
IAB - Italian Angels for Biotech
IAB provides an environment that facilitates interactions between interesting start-up projects and its members. Our goal is to identify and nurture top talent entrepreneurs in the Life Sciences sector. We lead equity investments to help ideas and start-ups to reach key objectives. Our value is beyond financing, we do not provide just angel money. We bring mentoring and expertise to great ideas by becoming entrepreneur partners. Our added value is in networking: we connect start-ups with international venture capitals, Life Sciences experts, strategic partners, industry veterans as well as service providers such as law firms, as well as other advisors or service companies. We usually take board seats and work closely with entrepreneurs to maximize the chances of success.